Literature DB >> 19444645

The Xmn1 polymorphic site 5' to the (G)gamma gene and its correlation to the (G)gamma:(A)gamma ratio, age at first blood transfusion and clinical features in beta-thalassemia patients from Western Iran.

Hooshang Nemati1, Zohreh Rahimi, Gholamreza Bahrami.   

Abstract

beta-Thalassemia is the most common single gene disorder in Iran and more than 25,000 affected individuals have been reported. It has been reported that in patients with beta-thalassemia in the presence of Xmn1 polymorphic site the level of Hb F and (G)gamma: (A)gamma ratio is increased. The prevalence of Xmn1 polymorphic site, (G)gamma: (A)gamma ratio and Hb F in 197 beta-thalassemia major patients from the Kermanshah Province of Iran were studied. The Xmn1 polymorphic site was determined by PCR-RFLP procedure. The levels of (G)gamma and (A)gamma chains were detected by HPLC. The percent of Hb F was determined using electrophoresis method. In beta-thalassemia major patients the frequency of presence Xmn1 was 0.39. The mean of (G)gamma: (A)gamma ratio was found to be 2.5. In the present study it was found that in the presence of Xmn1 polymorphic site (G)gamma percent and (G)gamma: (A)gamma ratio were significantly increased (P = 0.01) and the clinical features such as splenomegaly and bone marrow expansion were significantly improved (P = 0.01). We found that in the presence of Xmn1 polymorphic site on both chromosomes (+/+) the level of Hb F tended to be increased compared to the absence of Xmn1 (-/-). The present investigation has studied the frequency of Xmn1 polymorphic site in beta-thalassemia major patients from Western Iran and has revealed that the presence of this polymorphic site caused a positive influence on Hb F production and the (G)gamma percent which could improve the clinical symptoms of beta-thalassemia patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444645     DOI: 10.1007/s11033-009-9566-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  27 in total

1.  Beta-globin gene cluster haplotypes in sickle cell patients from southwest Iran.

Authors:  Z Rahimi; M Karimi; M Haghshenass; A Merat
Journal:  Am J Hematol       Date:  2003-11       Impact factor: 10.047

Review 2.  Advances in experimental treatment of beta-thalassaemia.

Authors:  G P Rodgers; Y Saunthararajah
Journal:  Expert Opin Investig Drugs       Date:  2001-05       Impact factor: 6.206

3.  XmnI polymorphism is associated with fetal hemoglobin levels in hypoplastic syndromes.

Authors:  Marily Maria Azevedo Shimmoto; Perla Vicari; Andréa Cristina Fernandes; Gustavo Stuani Guimarães; Maria Stella Figueiredo
Journal:  Sao Paulo Med J       Date:  2006-03-02       Impact factor: 1.044

4.  Association of -158 (C-->T) (XmnI) DNA polymorphism in G gamma-globin promoter with delayed switchover from fetal to adult hemoglobin synthesis.

Authors:  K G Peri; J Gagnon; C Gagnon; H Bard
Journal:  Pediatr Res       Date:  1997-02       Impact factor: 3.756

5.  Successful use of hydroxyurea in beta-thalassemia major.

Authors:  V R Arruda; C S Lima; S T Saad; F F Costa
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

6.  Variable clinical severity of Hb E beta-thalassemia among Indians.

Authors:  A Nadkarni; K Ghosh; A Gorakshakar; R Colah; D Mohanty
Journal:  J Assoc Physicians India       Date:  1999-10

7.  Differentiation of electrophoretically similar hemoglobins--such as S, D, G, and P; or A2, C, E, and O--by electrophoresis of the globin chains.

Authors:  R G Schneider
Journal:  Clin Chem       Date:  1974-09       Impact factor: 8.327

8.  Molecular pathogenesis and clinical variability of beta-thalassemia syndromes among Indians.

Authors:  A Nadkarni; A C Gorakshakar; C Y Lu; R Krishnamoorthy; K Ghosh; R Colah; D Mohanty
Journal:  Am J Hematol       Date:  2001-10       Impact factor: 10.047

9.  The beta-thalassemia mutation spectrum in the Iranian population.

Authors:  H Najmabadi; R Karimi-Nejad; S Sahebjam; F Pourfarzad; S Teimourian; F Sahebjam; N Amirizadeh; M H Karimi-Nejad
Journal:  Hemoglobin       Date:  2001-08       Impact factor: 0.849

10.  Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening.

Authors:  M Alebouyeh; F Moussavi; H Haddad-Deylami; P Vossough
Journal:  Ann Hematol       Date:  2004-01-14       Impact factor: 3.673

View more
  17 in total

1.  Influence of Xmn 1(G)γ (HBG2 c.-211 C → T) Globin Gene Polymorphism on Phenotype of Thalassemia Patients of North India.

Authors:  Ravindra Kumar; Anupriya Kaur; Sarita Agarwal
Journal:  Indian J Hematol Blood Transfus       Date:  2013-08-25       Impact factor: 0.900

2.  Rapid separation of human globin chains in normal and thalassemia patients by RP-HPLC.

Authors:  Hooshang Nemati; Gholamreza Bahrami; Zohreh Rahimi
Journal:  Mol Biol Rep       Date:  2010-03-05       Impact factor: 2.316

3.  Association of Xmn1 -158 γG variant with severity and HbF levels in β-thalassemia major and sickle cell anaemia.

Authors:  Sneha Dadheech; Suman Jain; D Madhulatha; Vandana Sharma; James Joseph; A Jyothy; Anjana Munshi
Journal:  Mol Biol Rep       Date:  2014-02-02       Impact factor: 2.316

4.  Plasma lipids and lipoproteins in children and young adults with major β-thalassemia from western Iran: influence of genotype.

Authors:  Hamid Madani; Zohreh Rahimi; Mohammad Manavi-Shad; Hadi Mozafari; Reza Akramipour; Asad Vaisi-Raygani; Mansour Rezaei; Shohreh Malek-Khosravi; Ebrahim Shakiba; Abbas Parsian
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

Review 5.  A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease.

Authors:  Gift D Pule; Shaheen Mowla; Nicolas Novitzky; Charles S Wiysonge; Ambroise Wonkam
Journal:  Expert Rev Hematol       Date:  2015-09-01       Impact factor: 2.819

6.  The XmnI polymorphic site 5' to the gene G(γ) in a Brazilian patient with sickle cell anaemia - fetal haemoglobin concentration, haematology and clinical features.

Authors:  Edis Belini Júnior; Rodolfo D Cançado; Claudia R B Domingos
Journal:  Arch Med Sci       Date:  2010-10-26       Impact factor: 3.318

7.  Genotypic Diversity among Angolan Children with Sickle Cell Anemia.

Authors:  Mariana Delgadinho; Catarina Ginete; Brígida Santos; Armandina Miranda; Miguel Brito
Journal:  Int J Environ Res Public Health       Date:  2021-05-19       Impact factor: 3.390

8.  What influences Hb fetal production in adulthood?

Authors:  Gisele Cristine de Souza Carrocini; Paula Juliana Antoniazzo Zamaro; Claudia Regina Bonini-Domingos
Journal:  Rev Bras Hematol Hemoter       Date:  2011

9.  Association between XmnI Polymorphism and HbF Level in Sickle Cell Disease Patients from Chhattisgarh.

Authors:  Sanjana Bhagat; Pradeep Kumar Patra; Amar Singh Thakur
Journal:  Int J Biomed Sci       Date:  2012-03

10.  Effect of Cis Acting Potential Regulators in the β Globin Gene Cluster on the Production of HbF in Thalassemia Patients.

Authors:  Pooja Dabke; Roshan Colah; Kanjaksha Ghosh; Anita Nadkarni
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-02-16       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.